ML Labs gets $17.5 million to speed trials
This article was originally published in Clinica
Executive Summary
Paul Capital Royalty Acquisition Fund has put $17.5 million into UK company ML Laboratories to speed product development and will get a proportion of royalty and revenues from three products until 2010. These include Adept, a product for the reduction of surgical adhesions.